This year’s “Fishing for a Cure,” an annual fundraiser hosted by Constellation Energy Corporation, has raised $70,000 for the…
Articles by Marisa Wexler, MS
Evoq Bio said it successfully completed a meeting with the U.S. Food and Drug Administration (FDA), held to discuss the…
Phage therapy, a promising strategy for treating antibiotic-resistant lung infections that’s currently in clinical trials, can trigger the release of…
Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) helps increase fat stores in adults with cystic fibrosis (CF), especially those who are…
Infections of Pseudomonas aeruginosa usually persist in people with cystic fibrosis (CF) after Trikafta is started, a…
A test of physical function called Glittre-ADL may be better than the standard six-minute walk test at identifying physical limitations…
Treatment with Trikafta (ivacaftor/tezacaftor/elexacaftor) eases nose and sinus symptoms in eligible patients with cystic fibrosis (CF), and the…
A five-year study led by scientists at Emory University in Georgia aims to identify new ways to improve quality of…
A novel treatment strategy for cystic fibrosis (CF) that’s based on a cellular structure called the porosome showed promise…
Biopharma and biotech companies have launched more than 450 clinical trials into potential new treatments for cystic fibrosis (CF)…